Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation
- PMID: 37026820
- DOI: 10.1111/ctr.14987
Multiple abnormal peripheral blood gene expression assay results are correlated with subsequent graft loss after kidney transplantation
Abstract
Background: The aim of this study was to correlate peripheral blood gene expression profile (GEP) results during the first post-transplant year with outcomes after kidney transplantation.
Methods: We conducted a prospective, multicenter observational study of obtaining peripheral blood at five timepoints during the first post-transplant year to perform a GEP assay. The cohort was stratified based on the pattern of the peripheral blood GEP results: Tx-all GEP results normal, 1 Not-TX had one GEP result abnormal and >1 Not-TX two or more abnormal GEP results. We correlated the GEP results with outcomes after transplantation.
Results: We enrolled 240 kidney transplant recipients. The cohort was stratified into the three groups: TX n = 117 (47%), 1 Not-TX n = 59 (25%) and >1 Not-TX n = 64 (27%). Compared to the TX group, the >1 Not-TX group had lower eGFR (p < .001) and more chronic changes on 1-year surveillance biopsy (p = .007). Death censored graft survival showed inferior graft survival in the >1 Not-TX group (p < .001) but not in the 1 Not-TX group. All graft losses in the >1 Not-TX group occurred after 1-year post-transplant.
Conclusions: We conclude that a pattern of persistently Not-TX GEP assay correlates with inferior graft survival.
Keywords: graft survival; kidney transplant outcomes; peripheral blood gene expression.
© 2023 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Merzkani MA, Bentall AJ, Smith BH, et al. Death with function and graft failure after kidney transplantation: risk factors at baseline suggest new approaches to management. Transplant Direct. 2022;8:e1273. doi: 10.1097/TXD.0000000000001273
-
- El-Zoghby ZM, Stegall MD, Lager DJ, et al. Identifying specific causes of kidney allograft loss. Am J Transplant. 2009;9:527-535.
-
- Loupy A, Vernerey D, Tinel C, et al. Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts. J Am Soc Nephrol. 2015;26:1721-1731. doi: 10.1681/ASN.2014040399
-
- Heilman RL, Devarapalli Y, Chakkera HA, et al. Impact of subclinical inflammation on the development of interstitial fibrosis and tubular atrophy in kidney transplant recipients. Am J Transplant. 2010;10:563-570. doi: 10.1111/j.1600-6143.2009.02966.x
-
- Scholten EM, Rowshani AT, Cremers S, et al. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J Am Soc Nephrol. 2006;17:2622-2632.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
